Infant Formula NEC

Infant Formula NEC Lawsuit — Premature Infant Bowel Injury Claims

Premature infants fed cow’s milk-based infant formula face substantially elevated risk of necrotizing enterocolitis (NEC) — a devastating bowel disease. Lawyers at Trial Lawyers United represent families of preterm infants who developed NEC after receiving Enfamil or Similac and suffered bowel perforation, sepsis, emergency surgery, short bowel syndrome, or death.

What is Necrotizing Enterocolitis (NEC)?

Necrotizing enterocolitis is a serious inflammatory bowel disease that occurs in premature and very low-birth-weight infants. The condition involves inflammation and tissue death (necrosis) in the infant’s intestines. Key features:

• Acute onset: Typically develops within the first 2–3 weeks of life in preterm infants.
• Progressive: Inflammation worsens rapidly; perforation and sepsis can develop within hours.
• Life-threatening: Mortality rates are 15–30% even with aggressive medical intervention.
• Permanent disability: Survivors often require multiple surgeries and face long-term gastrointestinal and nutritional problems.

NEC Symptoms and Clinical Presentation

Early signs of NEC include:

• Abdominal distension: Visible swelling of the abdomen.
• Feeding intolerance: Inability to tolerate breast milk or formula; residual feeds in the stomach.
• Bloody stools: Gross blood or blood in diaper.
• Temperature instability: Hypothermia (low body temperature).
• Lethargy and poor perfusion: Decreased responsiveness, pale or mottled skin.
• Rapid progression: Within hours, signs of sepsis, shock, and organ failure may develop.

Scientific Evidence: Formula and NEC Risk in Preterm Infants

Robust scientific evidence demonstrates that cow’s milk-based formula significantly increases NEC risk in preterm infants compared to breast milk:

• Breast milk protection: Breastfed preterm infants have substantially lower NEC rates (approximately 3–5%) compared to formula-fed infants (approximately 7–15%).
• Formula type matters: Exclusive human milk feeding is protective; cow’s milk-based formula is associated with elevated risk.
• Mechanistic evidence: Breast milk contains immunoglobulins, lactoferrin, and oligosaccharides that protect intestinal epithelium and support beneficial bacterial colonization. Formula lacks these components.
• Gut microbiota: Cow’s milk formula promotes colonization with potentially pathogenic bacteria; breast milk promotes beneficial Bifidobacterium and Lactobacillus species.
• Intestinal barrier: Preterm infants have immature intestinal barrier function; formula feeding allows bacterial translocation and endotoxemia.

The Products at Issue: Enfamil and Similac

Two manufacturers dominate infant formula in the United States:

• Enfamil (Mead Johnson, acquired by Reckitt Benckiser): Multiple product lines marketed for preterm and premature infants.
• Similac (Abbott Laboratories): Multiple product lines marketed for preterm and NICU use.

Both companies promoted cow’s milk-based formulas for premature infants despite knowing of NEC risk.

Allegations Against Formula Manufacturers

We allege that Mead Johnson/Reckitt and Abbott:

• Knew that cow’s milk-based formula significantly increased NEC risk in preterm infants.
• Knew that breast milk was protective and superior to formula.
• Marketed formula to hospitals and NICUs as a safe, adequate alternative to breast milk for preterm infants, downplaying or omitting NEC risk.
• Failed to adequately warn healthcare providers and parents of NEC risk.
• Prioritized market share and profits over the safety of vulnerable premature infants.

Serious Injuries from NEC and Medical Consequences

• Intestinal perforation: Inflammation progresses to full-thickness necrosis; bowel perforates into the peritoneal cavity.
• Emergency surgery: Peritonitis requires emergency exploratory surgery; necrotic bowel segments are resected.
• Short bowel syndrome: Extensive bowel resection results in insufficient intestinal length and absorption capacity.
• Parenteral nutrition dependence: Infants require long-term IV nutrition due to inability to absorb adequate nutrition orally.
• Chronic diarrhea and malabsorption: Ongoing gastrointestinal dysfunction.
• Sepsis: Bacterial translocation and infection; may progress to septic shock.
• Organ failure: Sepsis-related failure of kidneys, lungs, liver.
• Neurodevelopmental impairment: Sepsis and hypoxia may cause brain injury and cognitive impairment.
• Death: NEC is a leading cause of death in premature infants.

Who May Qualify for an Infant Formula NEC Claim?

• Parents and guardians of preterm infants who developed NEC.
• Infants who received Enfamil, Similac, or other cow’s milk-based formula while hospitalized.
• Medical records documenting prematurity, formula feeding history, and NEC diagnosis.
• Temporal relationship: NEC onset during or shortly after formula feeding.

MDL 3026: Infant Formula NEC Litigation in Northern Illinois

Infant formula NEC cases have been consolidated into Multi-District Litigation (MDL) No. 3026 in the U.S. District Court for the Northern District of Illinois. This centralized proceeding facilitates coordinated discovery and expert testimony regarding formula risk.

Frequently Asked Questions

My child survived NEC but has long-term complications. Can I recover damages for ongoing care?

Yes. If your child has short bowel syndrome, chronic malnutrition, developmental delay, or other permanent conditions resulting from NEC, you may recover damages for past and ongoing medical care, special education, assistive devices, and reduced life earnings capacity. The goal is to place your child and family in the position they would have been in had NEC not occurred.

What if my infant died from NEC? Can I still file a wrongful death claim?

Yes. Wrongful death claims are available for infants who died from NEC caused by formula manufacturer negligence. Damages include funeral costs, parental grief, and in some jurisdictions, the value of the lost life and lost inheritance.

Does it matter if the hospital, not the parents, chose the formula?

While hospital protocol played a role, manufacturers bear liability for marketing formula as safe for preterm infants when they knew of the NEC risk. We pursue claims against manufacturers regardless of who made the immediate feeding decision. Some cases may also involve hospital negligence claims.

How long ago did the NEC occur for my claim to be valid?

Statute of limitations varies by state but generally begins when the injury was discovered or should have been discovered. Even if NEC occurred years ago, your claim may not be time-barred if you can establish when you learned (or reasonably should have learned) of the manufacturer’s negligence. Contact us to discuss your timeline.